4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-009797
CVP, Chief Financial Officer sold 7,700 shares at $84.47 ($650,412)
- CVP, Chief Financial Officer acquired 7,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2025-12-09 | Option exercise 10b5-1 | +7,700 | $59.26 | $456,277 | 47,598 | D: show line 1 in the form |
| Ullem Scott B. CVP, Chief Financial Officer | 2025-12-09 | Sale 10b5-1 | −7,700 | $84.47 | $650,412 | 39,898 | D: show line 2 in the form |
| Open-market sales · 7,700 sh · avg $84.47 · $650,412 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2025-12-09 | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −7,700 | 39,000 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…